Allergan, Inc. (NYSE: AGN) today announced operating results for the
quarter ended December 31, 2011. Allergan also announced that its Board
of Directors has declared a fourth quarter ... read more
IRVINE, Calif., Nov. 9, 2011 /PRNewswire/ -- Emmy®-nominated actress Christina Hendricks, in partnership with Allergan, Inc. (NYSE: AGN), the maker of LATISSE® (bimatoprost ophthalmic solution) 0.03% is calling on women to help her in a final push to raise $500,000 for the Make-A-Wish Foundation by November 30 through the LATISSE® ... read more
IRVINE, Calif., Oct. 6, 2011 /PRNewswire/ -- Since BOTOX® Cosmetic (onabotulinumtoxinA) was approved by the U.S. Food and Drug Administration (FDA) almost 10 years ago, there have been approximately 11 million treatments administered. In that time, women's perceptions of BOTOX® Cosmetic have changed, and Allergan, Inc. (NYSE: AGN), maker ... read more